Vallon Pharmaceuticals Inc (VLON)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1349.922 | -140.956 | -184.362 | -200.28 | -112.501 | -366.826 |
Return on Equity (%) | -5637.908 | -205.762 | -547.955 | -426.352 | -172.157 | -1002.461 |
Return on Invested Capital (%) | -5639.216 | -193.023 | -611.494 | -447.836 | -172.639 | -875.586 |
Operating Margin (%) | N/A | N/A | -4788 | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -4822 | N/A | N/A | N/A |
Book Value Per Share | 0.001 | 0.018 | -0.323 | 0.854 | 0.174 | 0.08 |
Earnings Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
Cash Per Share | 0.005 | 0.021 | 0.024 | 0.543 | 0.28 | 0.557 |
Working Capital Per Share | 0.001 | 0.017 | -0.344 | 0.834 | 0.174 | 0.073 |
Operating Profit Per Share | N/A | N/A | 0.022 | N/A | N/A | N/A |
EBIT Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
EBITDA Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
Free Cash Flow Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.015 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 112,5M | 180,25M | 4,51M | 6,81M | 13,48M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 13,48M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,3M |
Ratio cours/bénéfice | -0,1 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,72 |
Ratio prix/valeur comptable | 5,01 |
Rendement de dividende | - |
Actions en circulation | 3,25M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales